ACADIA PHARMACEUTICALS INC (ACAD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ACAD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ACAD | Director | 59 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INCY | Chair of the Board | 59 | ["Managing Member of Baker Bros. Advisors LP","experienced investor in life sciences companies","significant strategic and financial expertise","extensive knowledge of the life sciences and biopharmaceuticals industries"] | ["Nominating and Corporate Governance","Compensation","Nominating and Corporate Governance Committee"] | 2026 |
| MDGL | Independent Chairman of the Board of Directors and Class I Director | 59 | ["Managing Member of Baker Bros. Advisors LP","Experience investing in life sciences companies","Experience serving on board of directors of other public companies in the life sciences industry"] | ["Audit","Compensation"] | 2026 |
| DNLI | Director | 58 | [] | [] | 2025 |
Biography sourced from the proxy statement filing.
Julian C. Baker has served as a director of the Company since December 2015. Mr. Baker is a Managing Member of Baker Bros. Advisors LP ( Baker Bros. ), a registered investment adviser focused on long-term investments in life-sciences companies. Mr. Baker founded Baker Bros. in 2000, together with his brother, Felix Baker, Ph.D. Prior to founding Baker Bros., Mr. Baker was a portfolio manager at Tisch Financial Management from 1994 to 1999. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker currently serves on the boards of directors of Incyte Corporation, Madrigal Pharmaceuticals, Inc. and Denali Therapeutics, Inc., each public companies. Mr. Baker also serves as a member or observer on the boards of directors of several privately held biotechnology companies. Within the past five years, Mr. Baker served on the board of directors of Prelude Therapeutics, Inc. and Alumis, Inc. The NCG Committee believes that Mr. Baker is qualified to serve as a member of our board of directors based on his extensive financial industry experience focused on life science companies.